Filing Details

Accession Number:
0001615774-18-004909
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-06 16:05:34
Reporting Period:
2018-06-01
Accepted Time:
2018-06-06 16:05:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346251 B John Rhodes C/O Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2018-06-01 7,500 $3.33 23,470 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct